Ray Co

Ray Co Capital Intensity

The Capital Intensity Ratio of Ray Co (228670.KQ) as of Nov 18, 2026 is 172.69 %. In the previous year, Capital Intensity Ratio was 255.77 % — a change of -32.48% (lower).

Capital Intensity

172.69 %

YoY

-32.48%

Last updated:

Capital Intensity Ratio of Ray Co is 2025 172.69 % . Capital Intensity Ratio of Ray Co was 2024 255.77 % . It decreases by -32.48% lower compared to the previous year.

The Ray Co Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
80.09 KRW
Jan 1, 2019
104.85 KRW
Jan 1, 2020
161.58 KRW
Jan 1, 2021
196.28 KRW
Jan 1, 2022
172.25 KRW
Jan 1, 2023
177.92 KRW
Jan 1, 2024
255.77 KRW
Jan 1, 2025
172.69 KRW
The Ray Co Capital Intensity history
YEARCapital IntensityYoY
172.69 %-32.48%
255.77 %+43.76%
177.92 %+3.29%
172.25 %-12.24%
196.28 %+21.47%
161.58 %+54.10%
104.85 %+30.92%
80.09 %+2.19%
78.37 %-14.69%
91.86 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Capital Intensity Ratio of Ray Co is 172.69 % in 2025.

Capital Intensity Ratio of Ray Co changed from 255.77 % to 172.69 %, representing a -32.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Ray Co since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Ray Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ray Co

All Key Metrics — Ray Co